Close menu




Investments

Photo credits: pixabay.com

Commented by Armin Schulz on November 23rd, 2022 | 12:10 CET

K+S, Defense Metals, RWE - Profiting from stocks that fight shortcomings

  • Mining
  • RareEarths
  • fertilizer
  • Investments

The first supply chain problems occurred during the Corona Pandemic. With the outbreak of the Ukraine conflict, further deficiencies of Western countries were exposed. It has been known for a long time that the US and Europe are dependent on raw materials and energy from Russia and China. The Middle Kingdom, in particular, already has a monopoly on critical raw materials such as rare earths and tungsten. There has been a minor trade war between the US and China for some time now. Russia has supplied both Europe and the US with cheap energy. Now in times of tension, the dependencies are coming out in the open. So today, we look at three stocks that can combat the shortage.

Read

Commented by Stefan Feulner on November 22nd, 2022 | 13:42 CET

Favorable starting positions for Commerzbank, Desert Gold and BioNTech

  • Mining
  • Gold
  • Investments
  • Biotechnology

The suspected downward pressure due to uncertainties in the economy and geopolitics has so far failed to materialize. Instead, the most important stock indices, such as DAX or Dow Jones, were able to leave their short-term downward trends and are sending signals for a further upward push. In addition to the stock market, the precious metals sector was also able to turn around. Here, in particular, entry opportunities beckon at a significantly reduced level with the chance of long-term, disproportionate price gains.

Read

Commented by André Will-Laudien on November 22nd, 2022 | 11:53 CET

Triple AAA stocks take off: Amazon, Aspermont, Alphabet, Allianz - Sellout done?

  • Fintech
  • Investments

Well, who would have thought: after 9 months of correction mode, the stock market is already returning to normal mode this year. The indicator for leaving the panic mode is the VDAX, i.e. the measured fluctuation range of the index in 12 months. Last week, it reached levels of 22 to 23 again, after peaking at 33 in September. By comparison, in the absolute panic phase at the start of the war, the volatility gauge was 48.6%. The mood has eased, so welcome to the year-end rally. Where are the best opportunities for investors?

Read

Commented by Stefan Feulner on November 21st, 2022 | 11:07 CET

Morphosys, Defence Therapeutics, Evotec - Stabilization after the sell-off

  • Biotechnology
  • Investments

After the publication of the figures for the third quarter, many biotech companies were able to surprise positively. Due to the partly panic-like sell-off in this capital-intensive sector, there are attractive entry opportunities at a strongly discounted level, which should pay off with disproportionate price gains in the long term. The fact that promising companies are already trading below their cash levels shows that the panic is exaggerated. There are currently signs of a bottoming out, which could herald the next upward wave.

Read

Commented by Juliane Zielonka on November 17th, 2022 | 13:48 CET

BioNxt Solutions, Pfizer, Bayer - Biotech and pharma stocks in focus

  • Biotechnology
  • Investments

Pharma and biotech companies are still booming. However, large corporations like Pfizer and Bayer need help maintaining their market dominance with long-term studies and patent extensions. Pfizer, in particular, experienced the rush of speed in recent years thanks to the emergency approval of the Covid-19 vaccine. In hindsight, however, voices are growing louder about the potential long-term damage of this market cut. Multi-million dollar lawsuits may result. Positioning itself in the mental health niche, whose market size was USD 381.98 billion in 2020, is BioNxt Solutions. Their mission: to tackle depression, anxiety and PTSD with natural substances. A look at the data.

Read

Commented by André Will-Laudien on November 17th, 2022 | 11:20 CET

The big catch-up - China Big Tech: Alibaba, Deutsche Bank, TUI and Desert Gold turn up the heat!

  • Travel
  • Investments

Investors increasingly look at the big losers in heavily sold markets because the size of the markdowns identifies potential for the future. Often shares fall because of the general market weakness, but sometimes the operating business also weighs heavy. At the end of the year, there is also "tax-loss selling", especially in North America. We look at some stocks that have suffered significant losses but could now take off again.

Read

Commented by Nico Popp on November 11th, 2022 | 11:36 CET

Jim Cramer warns, rally in the wings: Amazon, Commerzbank, Tocvan Ventures

  • Mining
  • Gold
  • Investments
  • ecommerce

The German Retail Association reports that Christmas sales this year could suffer from poor consumer sentiment. The culprit - who would have thought - inflation. We explain that the fight against inflation is anything but a foregone conclusion and how investors can potentially make a big profit from the current mixed situation, using the three shares below as examples.

Read

Commented by Stefan Feulner on November 10th, 2022 | 13:32 CET

Commerzbank, Aspermont, Munich Re - Financial stocks on the upswing

  • Investments
  • Banking

The end of the ultra-loose monetary policy and several larger interest rate steps already showed up positively in the half-year report of the major German banks. Should the ECB follow its big brother overseas, this promises further significant earnings potential. Financing platforms that combine the supply of scarce, promising commodity projects for the energy transition with demand from the capital market also hold great promise.

Read

Commented by Fabian Lorenz on November 10th, 2022 | 12:26 CET

Plug Power after the horror numbers, and what are Varta and Altech Advanced Materials doing?

  • Batteries
  • Electromobility
  • Investments

Climate change, high gas and oil prices and the dependence on "difficult" energy suppliers: There are many reasons why hydrogen and electromobility are among the undisputed topics of the future. Accordingly, shares from these sectors are popular with investors. Plug Power is one of the favorites. The Americans have disappointed (again) with their latest quarterly figures, but the share price is still rising, and analysts are also positive. Battery specialist Altech Advanced Materials is also currently doing well. The cooperation with Fraunhofer in the field of solid-state batteries is taking shape. Varta, on the other hand, is currently working on bottoming out, but analysts advise selling.

Read

Commented by Armin Schulz on November 7th, 2022 | 10:31 CET

BioNTech, Cardiol Therapeutics, Bayer - Strong growth in the pharmaceutical industry over the coming years

  • Biotechnology
  • Investments

Demographic change is bringing new customers to pharmaceutical and biotech companies. Worldwide, the population is getting older, and with it, the number of patients with dementia, cancer and heart disease. Experts estimate that the population over 65 will increase steadily until 2050. The 'pill gap' will start to have a real impact from 2030, and then the proportion of the aging population will rise again in proportion. Accordingly, all healthcare companies will see growth as the number of customers grows. So today, we look at three companies committed to better patient health.

Read